Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

The formulated gel is a promising treatment for alopecia areata.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Ritlecitinib is safe and may effectively treat alopecia areata.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Cyclosporine effectively treated a woman's stubborn skin condition.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

CTP-543 is generally safe for treating alopecia areata.